Cvs Health CORP Form 4 insider transactions

CVS Health's EVP, Chief DDAT Officer, Tilak Mandadi, reported the acquisition of restricted stock units and the disposal of common stock.

CVS Health director Larry Robbins reported transactions involving common stock, cash-settled swaps, and deferred stock units.

CVS Health director Douglas H. Shulman acquired 2,200 shares of common stock as part of a semi-annual retainer payment.

CVS Health director Guy P. Sansone acquired 2,200 shares of common stock as part of a semi-annual retainer payment.

CVS Health director Leslie V. Norwalk acquired 2,200 shares of common stock as part of a semi-annual retainer payment.

CVS Health director Mary L. Schapiro acquired 2,933.4501 deferred stock units on November 21, 2024, as part of her compensation.

CVS Health director Jean-Pierre Millon acquired 2,200 shares of common stock as part of a semi-annual retainer payment.

CVS Health director Michael F. Mahoney acquired 2,200 shares of common stock as part of a semi-annual retainer under the company's 2017 Incentive Compensation Plan.

CVS Health director J. Scott Kirby acquired 2,933 shares of common stock as part of a semi-annual retainer under the company's 2017 Incentive Compensation Plan.

Director Anne A. Finucane acquired 2,200.0876 deferred stock units of CVS Health, increasing her indirect holdings.

CVS Health director Nancy-Ann DeParle acquired 2,331 shares of common stock and holds deferred stock compensation.

CVS Health director Alecia A. DeCoudreaux acquired 2,200.0876 deferred stock units, convertible to common stock, as part of a semi-annual retainer.

CVS Health director C. David Brown II acquired 2,331 shares of common stock as part of a semi-annual retainer under the company's 2017 Incentive Compensation Plan.

CVS Health director Jeffrey R. Balser acquired 2,375 shares of common stock as part of a semi-annual retainer payment.

CVS Health director Fernando Aguirre acquired 2,364 shares of common stock as part of a semi-annual retainer under the company's 2017 Incentive Compensation Plan.

EVP and Chief Technology Officer of CVS Health, Tilak Mandadi, reports the surrender of shares for tax obligations related to vesting restricted stock units.

Director Mary L. Schapiro reports acquisition of share credits for deferred compensation, increasing her holdings in CVS Health.

Jean-Pierre Millon, a director at CVS Health, acquired 2,314 shares of common stock at $57.52 per share as part of the company's incentive compensation plan.

Director Michael F. Mahoney acquired 2,184 shares of CVS Health Corp common stock at $57.52 per share as part of a semi-annual retainer.

J Scott Kirby, a director at CVS Health Corp, acquired 2,912 shares of common stock as part of a semi-annual retainer payment.

Director Anne A. Finucane reports acquisition of share credits and updates to direct and indirect ownership of CVS Health Corp stock.

Director Roger Farah reports acquisition of share credits and deferred stock compensation in CVS Health Corp.

Nancy Ann DeParle, a director at CVS Health Corp, acquired 2,314 shares of common stock at $57.52 per share as part of the company's incentive compensation plan.

Alecia A. DeCoudreaux, a director of CVS Health Corp, acquired shares through a deferred compensation plan.

C. David Brown II, a director of CVS Health Corp, acquired 2,314 shares of common stock as part of a semi-annual retainer payment.

Director Jeffrey Balser acquired 2,184 shares of CVS Health common stock as part of a semi-annual retainer under the company's 2017 Incentive Compensation Plan.

Director Fernando Aguirre increased his holdings in CVS Health through the acquisition of 2,347 shares at a price of $57.52 per share.

Director Edward J. Ludwig reports purchasing 1,000 shares of CVS Health Corp stock at $53.879 per share.

Director Michael Mahoney reported the acquisition and disposal of CVS Health Corp stock through trusts on May 2, 2024.

James David Clark, SVP, Controller & Chief Accounting Officer of CVS Health Corp, reports changes in beneficial ownership of common stock and restricted stock units due to tax withholdings and new awards.